Thyrotropin and IgG from patients with Graves' disease induce class-II antigen on human thyroid cells by Wenzel, B. E. et al.
THE THYROID AND 
AUTOIMMUNITY 
Proceedings of the International Symposium on Thyroid and 
Autoimmunity, Amsterdam, 19-21 March 1986 
Editors: 
H .A. Drexhage 
Department of Pathology 
University Hospital of the Free University 
Amsterdam, The Netherlands 
W.M. Wiersinga 
Department of Endocrinology 
Academic Medical Centre 
Amsterdam, The Netherlands 




AUTOIMMUNE ASPECTS OF HYPERTHYROIDISM 
The role of antibodies and other humoral factors in the pathogenesis of Graves9 
disease 
S.H. I n g b a r 3 
Elisa for autoantibodies reacting with thyroid plasma membrane antigens in 
serum of patients with autoimmune thyroid diseases in comparison with anti 
T S H receptor antibodies assay 
A . G a r das a n d H . D o m e k 15 
Can porcine thyroid tissue replace human thyroid tissue in the assay of thyroid 
stimulating antibodies? 
S. de Rave, H . M . J . G o l d s c h m i d t , B . B r a v e n b o e r , Y.T.J. S o m e r s - P i j n e n b u r g 
a n d J . H . M . L o c k e f e e r 17 
Identification of different immunoglobulin G epitopes in Graves' disease 
A . G a r c i a - A m e i j e i r a s , A . D u q u e , E . R o s e l l a n d R. C o r c o y 19 
Isolation of both agonist and nonagonist Graves' Immunoglobulins from the sera 
of individual patients 
J . W o r t h i n g t o n , R L . H i m s w o r t h a n d P . G . H . B y f i e i d 21 
Characterization of T S H receptor antibodies in Hashimoto's thyroiditis and 
Graves' disease 
T. W.A. de B r u i n , L . E . B r a v e r man a n d R.S. B r o w n 23 
Thyroid stimulating antibody: An index of thyroid Stimulation in Graves' 
disease? 
L . B a l d e t , A M . M a d e c , C. P a p a c h r i s t o u , A . S t e f a n u t t i , J . O r g i a z z i a n d 
C. Jaffiol 26 
Detection of thyroid-stimulating antibodies in Graves' disease and in other 
thyroid diseases, employing rat thyroid fragment perifusion 
J . R . A t t a l i , P . V a l e n s i , D . D a r n i s , C. W e i s s e l b e r g a n d J . Sebaoun 2 9 
Thyroid-stimulating immunoglobulins (TSI) and thyroglobulin autoantibodies 
(h-TgAb) in Graves' disease 
P . H . de N a y e r , P . H . Sauvage, C. C o r n e t t e , M . - P . L a m b o t a n d C Beckers 33 
Graves9 disease; Factors associated with its development and subsequent course 
D . C.S. C h a n g , P.S. B a r n e t t , S. R a t a n a c h a i y a v o n g , C A . G u n n , C. D a r k e a n d 
A . M . M c G r e g o r 37 
The predictive value of pretreatment TSI measurements in Graves' disease 
B . B r a v e n b o e r , S. de Rave, H . M . J . G o l d s c h m i d t , Y.T.J. S o m e r s - P i j n e n b u r g 
a n d J . H . M . L o c k e f e e r 50 
xii 
The ability of the serum thyrotrophin receptor antibody (TRAb) index and 
H L A Status to predict long term remission of thyrotoxicosis following medical 
therapy for Graves' disease 
R. W i l s o n , J . H . M c K i l l o p , N . H e n d e r s o n , D . W. P e a r s o n a n d J . A . Thomson 52 
Thyroid antibodies in Africans with diffuse toxic goitre: Response to medical 
therapy 
W. J . K a l k a n d J . C. Santos 5 5 
Heterogeneity in juvenile thyrotoxicosis 
P . A . D a h l b e r g , P . W i l t o n a n d A . F . K a r l s s o n 58 
Follow up of 35 Graves' patients thyroid stimulating antibody activity during 
treatment: A prospective study 
G. Bakö a n d A . Leövey 61 
Monitoring of immunopathological events in Graves' patients during medical 
treatment: Immunological studies 
U. d i M a r i o , M . V i t i l l o , F . P . C a v a t o r t a , A . S c a r d e l l a t o , F . D o t t a , 
J . S u t h e r l a n d , P . P o z z i l l i a n d D . A n d r e a n i 64 
Evolution of thyrotropin-receptor antibodies and microsomal antibodies after 
radioiodine treatment of Graves' disease 
H . M . H e s h m a t i , M . I z e m b a r t , F . Dagousset a n d G. V a l l e e 67 
Dithiothreitol inhibits thyroid cell Stimulation of iodine organification by Graves' 
Immunoglobulins 
J . G i n s b e r g , D J . R a f t e r a n d P . G . M u r r a y 69 
AUTOIMMUNE ASPECTS OF HYPOTHYROIDISM 
Autoimmune hypothyroidism 
A . P i n c h e r a , G. F e n z i , L . C h i o v a t o a n d P . V i l l i 73 
Adsorption of thyroid microsomal fraction on plastic materials 
M . G e m b i c k i , K . - t a c k a , J . K o s o w i c z a n d J . Seidel 81 
Evidence that thyroid peroxidase is the *microsomal' antigen 
B . C z a r n o c k a , J . Ruf, M . F e r r a n d , S. L i s s i t z k y a n d P . C a r a y o n 84 
Evidence for identity of serum thyroid microsomal and anti-human thyroid 
peroxidase autoantibodies 
S. M a r i o t t i , R. B e c h i , S. A n e l l i , J . R u f A . L o m b a r d i , L . C h i o v a t o , 
B . C z a r n o c k a , P . C a r a y o n a n d A . P i n c h e r a 86 
Ultrastructural localization of microsomal antibodies on the surface of human 
thyroid follicle cells 
M . N i l s s o n , J . Mölne, F . A . K a r l s s o n a n d L . E . E r i c s o n 88 
Interaction between G M 3 ganglioside and Immunoglobulins from mothers of 
hypothyroid infants 
J . H . D u s s a u l t , D . B e r n i e r a n d J. Ruel 
Antibodies against 'second colloid antigen' in sporadic congenital 
hypothyroidism 
R . D . van der G a a g , A . M . B l o o t a n d H . A . D r e x h a g e 
Permanent and transient newborn hypothyroidism due to maternal autoimmune 
thyroiditis 
M . K l e t t , U. H e i n r i c h , M . Müller a n d D . Schönberg 
Hypothyroidism and autoimmune thyroid destruction: A role for thyroid 
autoantibodies? 
S. M c L a c h l a n , R. Jansson, P . Whitehead, C. Pegg a n d B . Rees Smith 
Thyroid pathology and function in experimental autoimmune thyroiditis of 
inbred mice 
S.C. I m a h o r i a n d A . O . V l a d u t i u 
In vivo activated T cells with natural killer (NK) activity in the thyroid infiltrate 
of patients with Hashimoto's thyroiditis 
G.F. D e l P r e t e , A . T i r i , S. M a r i o t t i , A . P i n c h e r a , S. Romagnani a n d 
M . R i c c i 
Activated H L A - D R - and IFN-7-expressing cytotoxic/suppressor T cells in 
thyroid tissue and peripheral blood of patients with subacute thyroiditis 
F . A . K a r l s s o n , T.H. Tötterman a n d R. Jansson 
The effect of replacement therapy on thyroid antibody and serum thyrotropin 
concentrations in Hashimoto's thyroiditis 
B . T r b o j e v i c , N . L a l i c a n d D . S l i j e p c e v i c 
Thyroid microsomal antibodies do not react with calcitonin-producing thyroid 
cells 
W.A. Scherbaum, H . M o g e l a n d E . F . Pfeiffer 
Thyroid autoimmunity in thyroid Cancer 
F . P a c i n i , S. M a r i o t t i , N . F o r m i c a , S. A n e l l i , R. Bechi, R. E l i s e i a n d 
A . P i n c h e r a 
Hyperthyroidism associated with histological Hashimoto's thyroiditis and 
thyroid papillary Carcinoma: Persistent antibody titres during one year after 
total thyroid resection without metastases 
M . Gomez-Balaguer, E. C a b a l l e r o , P . C o s t a , A . G i l s a n z , A . Ribasf E. B e r n a t 
a n d J. Esteban 
Immune dysregulation and the follow-up of athyrotic patients 
M . I z e m b a r t , H . M . Heshmati, H . Nasser a n d G. V a l l e e 
xiv 
An investigation of thyroid hormone autoantibodies in thyroid disease 
P . M e r l i n , A . B a l s a m o , L . M o n g a r d i a n d V. de F i l i p p i s 123 
ANTIGEN PRESENTATION AND THYROID AUTOIMMUNITY 
Inappropriate HLA class II expression of epithelial cells: Consolidation and 
progress 
/. T o d d , R. P u j o l - B o r r e l l , M . L o n d e i , M . F e l d m a n a n d G.F. Bottazzo 127 
The role of DR-expression on thyrocytes for the autoimmunity of the thyroid 
J . Teuber, R. Paschke, V. Schwedes a n d K . H . U s a d e l 139 
Thyrotropin and IgG from patients with Graves' disease induce class-II antigen 
on human thyroid cells 
B . E . Wenzel, R. G u t e k u n s t , T. M a n s k y , T. S c h u l t e k a n d P . C . S c r i b a 141 
Role of methimazole on DR antigen expression on human thyroid epithelial cell 
cultures 
J . - C C a r e l , J . - J . Remy, D . Z u c m a n , J . S a l a m e r o a n d J . C h a r r e i r e 145 
Purification of a 20 K D peptidic fragment from thyroglobulin (Tg) responsible 
for immunoreactivity towards monoclonal anti-Tg antibodies blocking the 
primary syngeneic sensitization 
J . S a l a m e r o , J . - J . Remy a n d J . C h a r r e i r e 148 
Are conserved regions on thyroglobulin thyroiditogenic? 
Y.M. K o n g , A . A . G i r a l d o , J . M . Justen, L . L . Simon a n d B . E . Füller 151 
Dendritic cells: Contributions to cell-mediated immunity 
R . M . Steinman 153 
Human thyroglobulin treatment of blood dendritic cells induces IgG antibody 
production in cultures from Hashimoto patients 
J . F a r r a n t , A . E . B r y a n t , J . C h a n a n d R . L . H i m s w o r t h 164 
Antigen-presenting cells (APC's) and the thyroid auto-immune response in the 
B B / W r a t 
H . A . M . V o o r b i j , P . J . K a b e l a n d H . A . D r e x h a g e 166 
AUTOIMMUNE ASPECTS OF SPORADIC AND ENDEMIC GOITER 
Thyroid growth stimulating Immunoglobulins (TGI) and goitre 
H . A . D r e x h a g e a n d R . D . v a n der G a a g 173 
Increased T helper/T suppressor-cytotoxic lymphocyte ratio in sporadic nontoxic 
goitre 
A . B e r g h o u t , W.M. W i e r s i n g a a n d H . A . D r e x h a g e 187 
What is thyroid growth promoting activity (TGI ' )? 
R. Gärtner, W. G r e i l , C T z a v e l l a , A . W i t t e a n d CR. P i c k a r d t 191 
XV 
Thyroid growth Stimulation by a (FAB)2-fragment prepared from an IgG of a 
TGI-positive nontoxic goitre patient 
R.A.P. van der Meer, R . D . van der G a a g a n d H . A . D r e x h a g e 193 
Possible significance of IgG thyroid stimulators in nontoxic goitre 
P . P . A . Smyth, B . G r u b e c k Loebenstein a n d T.J. M c K e n n a 196 
Thyroid growth promoting antibody in patients with non toxic goiter 
C M . R o t e l l a , C. M a v i l i a , L . D . K o h n a n d R. T o c c a f o n d i 198 
Autoimmunity in nodular goiter 
K . Westermark, P . Persson, H . Johansson a n d A . K a r l s s o n 202 
Autoimmunity in black African multinodular goitres 
J. E. C Santos a n d W. J. K a l k 204 
Growth promoting effects of T S H and E G F in isolated porcine thyroid follicles 
and occurrence of thyroid growth stimulating immunoglobulins in euthyroid 
goitre patients from an iodine-deficient endemic goitre area 
H . Schatz, R. Bär, F. Müller, J . - A . N i c k e l a n d H . Stracke 207 
Thyroid growth promoting activity in endemic goiter 
A . H a l p e r n , G. M e d e i r o s - N e t o a n d I . D . K o h n 209 
Thyroid autoantibodies after iodine supplementation 
D . A . K o u t r a s , KS. K a r a i s k o s , K . E v a n g e l o p o u l o u , M . A . B o u k i s , 
G . D . P i p e r i n g o s , J. K i t s o p a n i d e s , D . M a k r i y a n n i s , J. Mantzos, 
J. S f o n t o u r i s a n d A . Souvatzoglou 211 
Thyroiditis induced by dietary iodine may be due to the increased 
immunogenicity of highly iodinated thyroglobulin 
R.S. Sundick, D . H e r d e g e n , T.R. B r o w n a n d N . B a g c h i 213 
Amiodarone thyroid autoimmunity relationship? 
M . Gomez-Balaguer, E. C a b a l l e r o , P . C o s t a , A . G i l s a n z , E. B e r n a t , C. U r i e l 
a n d V. A l f o n s o 215 
Autoimmunity in nodular goiter? 
H St uder, H . G e r b e r a n d H J . Peter 217 
Studies on the natural history of toxic nodular goitre 
P . P . A . Smyth, D . F . Smith a n d TJ. M c K e n n a 221 
Intrathyroidal helper/inducer T cells and activated T cells in patients with 
euthyroid nodular goiter 
A . B a l s a m o , F . B o t t o M i c c a , P . M e r l i n , V. de F i l i p p i s a n d A . S t r a m i g n o n i 229 
Intrathyroidal immunological abnormalities in variants of endemic goitre 
B . Grubeck-Loebenstein, K . K r i s c h , H . Kassal, P . P . A . Smyth a n d 
W. W a l d h a u s l 231 
xvi 
Morphometric evidence for regional differences of thyroid hyperfunction in 
Graves' disease caused by lymphocytes 
R. Paschke, P . Pßester, A . H e s s e n b r u c h , J . W i n t e r , J . Teuber, U. Schnedes 
a n d K . H . V s a d e l 234 
Structural and functional heterogeneity in Graves' disease tissue 
H . - W . Müller-Gärtner a n d C. Schneider 236 
AUTOIMMUNE ASPECTS OF ENDOCRINE OPHTHALMOPATHY 
Humoral immunity and endocrine ophthalmopathy 
P K e n d a l l - T a y l o r 241 
Thyroid antibodies in endocrine ophthalmopathy 
K B e c h , V. Feldt-Rasmussen, Ä.Krogh Rasmussen, M . B l i c h e r t - T o f t , 
H . B l i d d a l , S. F a u r s c h o u a n d D . M a r u s h a k 245 
Humoral immunity in Graves' ophthalmopathy 
J . N a u m a n , M . F a r y n a a n d A . G a r d a s 248 
Detection of IgG and IgM antibodies directed against eye and peripheral muscle 
preparations in juvenile and adult patients with Graves' disease and in patients 
with hypothyroidism 
U. Bemetz, R. M o n c a y o , W. S c h e r b a u m , H . F r i s c h , K . B a d e n h o o p , G. H o o l , 
H . Schleussener a n d E . F . Pfeiffer 250 
Spontaneous and therapy induced course of eye muscle antibodies in endocrine 
ophthalmopathy (EO) 
G. K a h a l y , R. M o n c a y o , U. Bemetz, U. K r a u s e , J . Schrezenmeir, J . Beyer 
a n d E . F . Pfeiffer 253 
Current Status of autoantibodies against orbital antigens in the pathogenesis of 
Graves9 ophthalmopathy 
M . S a l v i , Y. H i r o m a t s u , L . Wosu, E . L a r y e a , J . H o w a n d J . R . W a l l 255 
Preliminary characterization of the soluble eye muscle antigen in the 80000xg 
supernatant using FPLC-anion exchange chromatography 
R. M o n c a y o , U. Bemetz a n d E . F . Pfeiffer 267 
Studies of cell-mediated immunity in Graves' ophthalmopathy using the 
antigen-induced leukocyte procoagulant activity assay 
J . H o w , A . M i l l e r , E . A . L a r y e a a n d J . R . W a l l 270 
Role of H L A class II antigen expression on normal human eye muscle cells and 
orbital fibroblasts in Graves' ophthalmopathy 
Y. H i r o m a t s u , L . Wosu, J . D o r n a n a n d J . R . W a l l 272 
Lymphocyte subsets in Graves' ophthalmopathy patients 
R. v a n der G a a g , L . B r o e r s m a , L . K o o r n n e e f a n d W.M. W i e r s i n g a 275 
xvii 
Treatment of severe Graves' ophthalmopathy with cyclosporin A alone and in 
combination with corticosteroids 
C h . U t e c h , K G . W u l l e , E . B i e l e r a n d N . P a n i t z 278 
IMMUNE DYSREGULATION IN THYROID DISEASE 
The role of immune dysregulation in the pathogenesis of autoimmune thyroid 
disease 
R. Volpe 283 
Activated (Ia +) T-cell subsets in autoimmune thyroid diseases 
J . Y. C. C h a n a n d P . G. W a l f i s h 294 
Circulating activated T cells in Graves' disease 
N . Genetet, G. M e r d r i g n a c , H . A l l a n n i c , G. E d a n , A . R o u g h o l a n d B . Genetet 296 
Impact of T helper and T suppressor cells on the production of anti-thyroglobulin 
antibodies in autoimmune thyroiditis 
J . Petersen a n d U. Feldt-Rasmussen 299 
In vitro production of thyroglobulin specific helper factor in humans 
K. Sato, Y. H a r a , S. S a k u r a i , Y. Sakatsume, T. T a n i k a w a , J . I s h i i a n d 
L J . D e g r o o t 302 
Is cellular immunity to the T S H receptor restricted to patients with Graves' 
disease? 
S. V e n t o , C J . O ' B r i e n , T. C u n d y , R. W i l l i a m s a n d A . L . W . F . E d d i e s t o n 304 
B cell activity in Graves' disease 
R. W i l s o n , J . H . M c K i l l o p a n d J . A . Thomson 306 
Antigen and mitogen induced differentiation of circulating B cells in patients 
with autoimmune thyroid disease (AIT) and normal individuals 
T. L o g t e n b e r g , A . K r o o n , F . H J . G m e l i g - M e y l i n g a n d R.E. B a l l i e u x 308 
Thyroglobulin epitopes and anti-thyroglobulin idiotypes in autoimmune thyroiditis 
D. M a l e , G. P r y c e , B . C h a m p i o n a n d I . R o i t t 311 
Detection and significance of anti-idiotypic-AB(a-ID-Ab) for autoimmune 
thyroid diseases 
U. Schnedes, J . Teuber, R. Paschke, J . C h r i s t o p h e l a n d K . H . U s a d e l 319 
Modulation of the immune response by thioureylene anti-thyroid drugs 
D J . K e r r , M . M . F e r g u s o n , J . M c G r o a r t y , A . R . M c L e l l a n a n d 
W.D. A l e x a n d e r 321 
Serum thyrotrophin receptor antibody (TRAb), thyroxine (T 4) and 
Tr i -iodothyronine (T 3) levels in patients receiving Carbimazole and 
Propylthiouracil (PTU) 
J . A . T h o m s o n , R. W i l s o n a n d J . H . M c K i l l o p 323 
xviii 
Graves' disease patients treated with Carbimazole: Thyroid stimulating 
immunoglobulins (TSab) assay and T cell subset counts after 5 years of 
remission following drug withdrawal 
H . A l l a n n i c , N . Genetet, N . M a s s a r t a n d B . Genetet 326 
Index of authors 329 
Subject index 333 
• 1 9 8 6 Elsevier Science Publishers B. V. ( B i o m e d i c a l D i v i s i o n ) 
The thyroid and autoimmunity. 
H.A. D r e x h a g e and W.M. [Viersinga, eds. 141 
T H Y R O T R O P I N AND I g G F R O M P A T I E N T S W I T H G R A V E S D I S E A S E I N D U C E C L A S S -
I I A N T I G E N ON HUMAN T H Y R O I D C E L L S . 
B. E. W E N Z E L , R. G U T E K U N S T , T. M A N S K Y , T. S C H U L T E K , P. C. S C R I B A 
K l i n i k f ü r I n n e r e M e d i z i n , M e d . U n i v e r s i t ä t z u L ü b e c k ; F . R . G e r m a n y 
I N T R O D U C T I O N 
We w e r e i n t e r e s t e d i n w h i c h p o t e n t i a l i n v i v o r e g u l a t o r s o f 
t h y r o i d c e l l f u n c t i o n s c o u l d m o d u l a t e H L A - D e x p r e s s i o n . We i n v e s t i -
g a t e d t h e p o s s i b i l i t y t h a t t h e r e m i g h t e x i s t a m e c h a n i s m t o i n d u c e 
H L A - D e x p r e s s i o n d i f f e r e n t t h a n t h e w e l l d o c u m e n t e d p a t h w a y v i a I F N 
( 1 , 2 , 3 ) . N a m e l y , t h e c h r o n i c S t i m u l a t i o n o f t h e T S H - r e c e p t o r a n d / o r 
t h e a d m i n i s t r a t i o n o f i o d i n e i n t h y r o i d m o n o l a y e r s ( T M ) g r o w n i n 
c u l t u r e m e d i u m w i t h o r w i t h o u t s e r u m s u p p 1 e m e n t a t i o n w a s s t u d i e d . 
T h i s s h o u l d c l a r i f y t h e r o l e t h a t p o l a r i t y o f t h r e e d i m e n s i o n a l 
s t r u c t u r e s p l a y s i n a n t i g e n - p r e s e n t a t i o n i n v i t r o a s s u g g e s t e d 
i n v i v o ( 4 ) . 
M A T E R I A L AND M E T H O D S 
S u b j e c t s : T h y r o i d t i s s u e f r o m p a t i e n t s w i t h G r a v e s ' d i s e a s e ( G D ) 
o r n o n t o x i c g o i t e r ( N T G ) w a s o b t a i n e d a t s u r g e r y . G D - p a t i e n t s h a d 
T S I - a n d 6 o u t o f 7 m i c r o s o m a l a n t i b o d i e s . 
T h y r o i d c e l l m o n o l a y e r s ( T M ) : T h y r o i d t i s s u e w a s m i n c e d , w a s h e d 
i n t e n s i v e l y w i t h c a l c i u m - a n d m a g n e s i u m - f r e e p h o s p h a t e b u f f e r 
s a l i n e ( P B S ) a n d d i g e s t e d e n z y m a t i c a l l y t w o t i m e s f o r 1 h o u r a t 3 7 ° 
C w i t h 4 m g / m l c o l l a g e n a s e . T h y r o i d c e l l s w e r e w a s h e d t w i c e i n P B S 
c o n t a i n i n g 1 0 % f e t a l c a l f s e r u m ( F C S ) , s e p a r a t e d f r o m e r y t h r o c y t e s 
a n d a u t o - r o s e t t e s b y d e n s i t y c e n t r i f u g a t i o n , w a s h e d , a n d p l a t e d o n 
8 C h a m b e r g l a s s s l i d e s ( 2 0 x 1 0 ^ / c h a m b e r ) i n t h e a p p r o p r i a t e m e d i u m . 
C e l l c u l t u r e s : Two i n c u b a t i o n m e d i a w e r e u s e d : I s c o v e m e d i u m w i t h 
5 ?o F C S a n d g l u t a m i n e o r I s c o v e s u p p l e m e n t e d w i t h i n s u l i n , h y d r o -
c o r t i s o n , h u m a n t r a n s f e r r i n , s o m a s t a t i n , g 1 y c y 1 - 1 - h y s t i d y 1 - 1 -
l y s i n e a c e t a t e a n d 0 , 5 % F C S ( 5 H ) . C e l l s w e r e a l l o w e d t o a d h e r e 
o v e r n i g h t t o t h e g l a s s s l i d e s . A f t e r w a s h i n g w i t h m e d i u m , s l i d e s 
• w e r e c u l t u r e d f o r a f u r t h e r 4 - 5 d a y s w i t h , w i t h o u t - o r c o m b i -
n a t i o n s o f t h e f o l l o w i n g a g e n t s : P H A ( 0 . 5 [ i g / m l ) , b T S H ( 1 - 1 0 0 
m U / m l ) , N a J ( 0 . 1 mM) a n d I g G ( 0 . 1 m g / m l ) . 
I n d i r e c t I m m u n o f l u o r e s c e n c e ( I F ) A f t e r 5 d a y s TMs w e r e w a s h e d a n d 
i n c u b a t e d w i t h m o n o c l o n a l a n t i b o d i e s : T ü 2 2 - s p e c i f i c f o r H L A - D Q , 
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T ü 3 5 - s p e c i f i c f o r HL A - D P / D R , T ü 3 9 - s p e c i f i c f o r H L A - D R / D P ( B I O -
T E S T ) , D A K 0 - D R C 1 s p e c i f i c f o r d e n d r i t i c r e t i c u l u m c e l l s , 
D A K 0 - T 1 / T 2 , s p e c i f i c f o r T - c e l l s ( e q u i v a l e n t t o 0 K T 1 ) , D A K O - D R 
r e a c t i n g w i t h t h e ß - c h a i n a n d D A K O - M a c r o p h a g e . F o r s t a i n i n g w i t h 
K i 6 7 ( D I A N O V A ) , w h i c h i s s p e c i f i c f o r a n u c l e a r p r o l i f e r a t i o n 
a n t i g e n ( 5 ) , T M s w e r e f i x e d w i t h a c e t o n e . T h e M - a n t i g e n o f t h y r o i d 
c e l l s w a s s t a i n e d w i t h i n a c t i v a t e d , d i l u t e d p a t i e n t s s e r a (<*-M 
2 
1 : 3 2 0 ; n e g a t i v e f o r d - T g ) . R a b b i t - a n t i g e n - m o u s e I g G ( F ( a b ) ^ ) -
F I T C a n d T R I T C c o n j u g a t e d r a b b i t - a n t i - h u m a n I g G w e r e u s e d a s 
s e c o n d a n t i b o d i e s . I F w a s a s s e s s e d w i t h a n O l y m p u s p h o t o f l u o r e s c e n -
c e - m i c r o s c o p e B - H 2 . 
F u r t h e r p r o c e d u r e s I g G s w e r e p r e p a r e d b y i o n e x c h a n g e c h r o m a t o -
g r a p h y . I g G s f r o m GD p a t i e n t s w e r e T S I a n d < * - M p o s i t i v e , w h i l e I g G s 
f r o m N T G a n d n o r m a l s h a d n o a u t o a n t i b o d i e s a s m e a s u r e d b y s p e c i f i c 
E L I S A S . 
F i g . 1 . H L A - D R a n d M - a n t i g e n e x p r e s s e d b y t h y r o i d m o n o l a y e r s 
p r e i n c u b a t e d w i t h 1 0 m U / m l b T S H i n 5H m e d i u m ; l e f t : b r i g h t 
l i g h t ; m i d d l e : H L A - D R ; r i g h t : M - a n t i g e n . O r i g i n a l m a g n i f i c a t i o n * 2 5 0 
R E S U L T S 
We d e m o n s t r a t e d s i m u l t a n o u s e x p r e s s i o n o f H L A - D R a n d m i c r o s o m a l 
a n t i g e n b y t h y r o i d c e l l s i n c u b a t e d i n s e r u m - f r e e m e d i u m w i t h b T S H 
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E x p r e s s i o n o f H L A -DR, M i c r o s o m a l - a n d K i 6 7 a n t i g e n i n t h y r o i d 
m o n o l a y e r s d e r i v e d f r o m G D - p a t i e n t s . 
5H M e d i u m F C S 
DR M K i 6 7 DR M K i 6 7 
P H A a-
+++ 
0 0 +++ 0 0 n = 7 
T S H ++ +++ + 0 +++ + n = 7 
I g G * ++ +++ n d 0 +++ n d n = 3 
I g G 0 0 +++ n d 0 +++ n d n = 7 
T p N T G 
I g G 0 0 n d 0 0 n d n = 7 
N a J 0 0 0 0 0 0 n = 7 
M e d i u m ( + )
b ( + ) + + 0 ( + ) + n = 3 / 7 
a - s u b j e c t i v e l y a s s e s s e d I F b - e x p r e s s e d s p o n t a n o u s l y 
* - h y p e r t h y r o i d G D - p a t i e n t o - e u t h y r o i d G D - p a t i e n t 
NTG - n o n t o x i c n o d u l a r g o i t e r n d - n o t d o n e 
( F i g . 1 ) o r I g G f r o m h y p e r t h y r o i d G D - p a t i e n t s ( T a b l e I ) . T h e H L A -
DR e x p r e s s i o n i n T M s w a s c o n f i n e d t o 3 d i m e n s i o n a l , f o 1 1 i c 1 e - 1 i k e 
s t r u c t u r e s w h i c h c o i n c i d e d w i t h t h e s t a i n i n g o f K i 6 7 , a p r o l i f e r a -
t i o n a n t i g e n ( 5 ) . T h i s m i g h t i n d i c a t e t h a t c h r o n i c S t i m u l a t i o n o f 
t h e T S H - r e c e p t o r c o u l d a l s o i n d u c e H L A - D R e x p r e s s i o n . M o r e o u e r , 
t h e p o l a r i t y o f t h e 3 d i m e n s i o n a l s t r u c t u r e s o f TMs m i g h t a c c o u n t 
f o r t h e a b s e n c e o f H L A - D R i n c u l t u r e s c o n t a i n i n g F C S ( a p i c a l u p ) , 
w h i l e DR i s p r e s e n t u n d e r s e r u m - f r e e c o n d i t i o n s ( p o l a r i t y , 
r e v e r s e d ) ( T a b l e I ) ( 6 ) . S i n c e t h e e x p r e s s i o n o f c l a s s I I a n t i g e n 
w a s a t t r i b u t e d t o c o n t a m i n a t i o n o f T M s w i t h l y m p h o c y t e s , we i n -
v e s t i g a t e d f o r m a r k e r s o f d e n d r i t i c , T - c e l l s o r m a c r o p h a g e s a f t e r 
p l a t i n g a n d a f t e r 5 d a y s i n c u b a t i o n ( T a b l e I I ) . O n l y c u l t u r e s w i t h 
F C S s h o w e d a w e a k s t a i n i n g f o r m a c r o p h a g e s o r d e n d r i t i c c e l l s a f t e r 
p l a t i n g , w h i c h d i s a p p e a r e d d u r i n g t h e i n c u b a t i o n p e r i o d . On t h e 
o t h e r h a n d , we c o u l d n o t p r o v e i n t e r l e u k i n 1 i n TM s u p e r n a t a n t s . 
T h e a t t e m p t t o b l o c k h y p o t h e t i c a l l y p r o d u c e d I F N # w i t h c y c l o -
s p o r i n A g a v e i n c o n c l u s i v e r e s u l t s . I n c u b a t i o n o f T M s w i t h 5 f i g / m l 
c y c l o s p o r i n A a n d b T S H d e t a c h e d t h y r o i d c e l l s f r o m s l i d e s a n d 
n e i t h e r -DR n o r M - a n t i g e n w a s d e t e c t a b l e t h e r e a f t e r . F i n a l l y , 
s u p e r n a t a n t s f r o m T M s d i s p l a y i n g -DR s p o n t a n o u s l y ( T a b . I ) c o u l d 
n o t i n d u c e -DR o n s e c o n d a r y T M s ( n o t s h o w n ) . I n c o n t r a s t t o o t h e r s ; 
144 
T A B L E I I 
E x p r e s s i o n o f H L A - D P o l y m o r p h i s m , L y m p h o c y t e , M a c r o p h a g e a n d 
d e n d r i t i c c e l l a n t i g e n s i n t h y r o i d m o n o l a y e r s d e r i v e d f r o m 
G D - p a t i e n t s . 
DR D P / D R DQ T l / 2 0M D R C 1 
( 5 H ) P H A +++ ++ 0 0 0 0 
i i T S H ++ + 0 0 0 0 
i i I g G 
++ + 0 0 0 0 
1 6 h 1 0 n d n d 0 0 0 
i i 5 d 2 ( + ) 0 0 0 0 0 
( F C S ) 1 6 h 1 0 n d n d 0 + + 
1 a f t e r p l a t i n g 2 5 d a y i n c u b a t i o n 
( 2 , 3 ) we c o u l d n o t f i n d t h e -DQ l o c i o f H L A - D p o l y m o r p h i s m i n TMs 
e x p r e s s i n g -DR a n t i g e n , a l t h o u g h t a n i n d u c t i o n i o f c l a s s I I a n t i -
g e n v i a I F N w o u l d l e a d p r e f e r e n t i a 1 1 y t o -DQ e x p r e s s i o n o f T M s ( 7 ) 
A C K N O W L E D G M E N T S 
T h e e x p e r t t e c h n i c a l a s s i s t a n c e o f M s . S. G r a m m e r s t o r f i s 
g r e a t l y a p p r e c i a t e d . 
T h i s p r o j e c t w a s s u p p o r t e d b y " D e u t s c h e F o r s c h u n g s g e m e i n s c h a f t " 
S F B 2 3 2 / C 4 . 
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